ATTENTION ISSUES AND FINDINGS (re: ADD/ADHD) IN THE NEWS:

Tuberculosis Meningitis and Attention Deficit Hyperactivity Disorder in Children

Journal of Tropical Pediatrics 2002 48(5):294-299; doi:10.1093/tropej/48.5.294
© 2002 by Oxford University Press

 

FDA Directs ADHD Drug Manufacturers to Notify Patients about Cardiovascular Adverse Events and Psychiatric Adverse Events

"Medicines approved for the treatment of ADHD have real benefits for many patients but they may have serious risks as well," said Steven Galson, M.D., MPH, Director, Center for Drug Evaluation and Research (CDER).